Olema Pharmaceuticals, Inc. OLMA

Updated: 16 Jun 2026

NASDAQ | Biotech | Targeted therapies for women's cancers

No signal published yet

We already track Olema Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Olema Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Targeted therapies for women's cancers
We're already tracking Olema Pharmaceuticals, Inc. — here are the latest events we've registered

Recent News

  • In May 2026, Olema announced a clinical trial collaboration with Bayer to evaluate its KAT6 inhibitor, OP-3136, in combination with darolutamide for metastatic prostate cancer. The company also presented encouraging initial Phase 1 data for OP-3136 at the 2026 ASCO Annual Meeting, demonstrating anti-tumor activity across multiple solid tumor types. Top-line data from the pivotal Phase 3 OPERA-01 trial of palazestrant is anticipated in the fall of 2026.

What Firelda Watch includes for Olema Pharmaceuticals, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Olema Pharmaceuticals, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
Ionis Pharmaceuticals, Inc.
IONS
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow Olema Pharmaceuticals, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Olema Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Olema Pharmaceuticals, Inc. OLMA
Olema Pharmaceuticals — follow and we'll monitor it
Follow Olema Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.